[The 2002/2003 influenza season in the Netherlands and the vaccine composition for the 2003/2004 season]

J C de Jong1, G F Rimmelzwaan, A I Bartelds

  • 1Erasmus Medisch Centrum, afd. Virologie, Postbus 1738, 3000 DR Rotterdam. jc.de.jong@wxs.nl

Insights

The 2002/2003 influenza season saw moderate activity with equal numbers of Influenza A (H3N2) and B viruses circulating. A concerning H3N2 variant emerged, prompting a potential vaccine mismatch for the upcoming season.

Area of Science:

  • Virology and Epidemiology
  • Public Health Surveillance

Context:

  • The 2002/2003 influenza season experienced a late start and moderate intensity, with Influenza A (H3N2) and B viruses co-circulating.
  • Influenza A (H3N2) viruses predominated in hospital isolates, while general practitioner data showed equal prevalence of H3N2 and B strains.

Purpose:

  • To analyze the circulating influenza strains during the 2002/2003 season and assess their relationship to vaccine reference strains.
  • To inform influenza vaccine composition recommendations for the 2003/2004 season based on epidemiological data and viral characteristics.

Summary:

  • Most H3N2 isolates were antigenically similar to the A/Moscow/10/99 vaccine strain, but a significant variant, A/Fujian/411/02, emerged later in the season.
  • Influenza A (H1N1) and B virus isolates were closely related to their respective vaccine strains.
  • An outbreak of avian influenza A (H7N7) in the Netherlands resulted in human infections, including one fatality, with no evidence of reassortment with human or swine influenza viruses.

Impact:

  • The emergence of the A/Fujian/411/02 variant poses a risk of reduced vaccine effectiveness for the 2003/2004 season.
  • The World Health Organization recommended maintaining the same vaccine composition for 2003/2004, highlighting the ongoing surveillance need.
  • The H7N7 outbreak underscores the potential for zoonotic transmission and the importance of monitoring avian influenza in human populations.